약물 남용 치료 시장 : 유형별, 치료법별, 연령층별, 치료 환경별, 지역별

Substance Abuse Treatment Market is estimated to be valued at USD 12.88 Bn in 2026 and is expected to reach USD 23.55 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.

Substance abuse treatment refers to programs and activities that are aimed at managing substance dependence and support long-term sobriety and recovery. Substance abuse disorder which is also known as addiction, involves the compulsive or uncontrollable use of harmful and addictive substances despite their negative impact. Common substances of abuse include alcohol, opioids, cannabis, cocaine, and methamphetamines. Some key signs of substance abuse disorder include the inability to reduce intake, experiencing cravings, and having withdrawal symptoms when not using. Those suffering from addiction often experience impaired control, social problems, risky use, and sometimes even physical dependence. Substance abuse treatment aims to address the biological, psychological, social, and behavioral aspects of addiction through therapeutic interventions, counseling, medication, and community support programs. The rise in substance abuse rates globally is fueling demand for effective treatment options.

Market Dynamics

Global substance abuse treatment market is driven by the rising prevalence of substance abuse disorders, increasing awareness regarding treatment availability, favorable regulations and reimbursement policies, and the launch of novel medication-assisted treatment products. However, the market growth can be restrained by social stigmas that are associated with addiction, lack of access to treatment facilities in low-income regions, and non-compliance issues with treatment protocols. The development of digital therapeutic solutions, integrated care models, targeted therapies for specific addictions, and expansion to emerging markets present key opportunities for the market players. Geographically, North America dominates the market due to advanced healthcare infrastructure and awareness. However, the Asia Pacific region is expected to offer lucrative growth prospects during the forecast period.

Key Features of the Study

• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global substance abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Indivior PLC, Pfizer, Inc., Johnson & Johnson Inc., Alkermes., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Inc., Par Pharmaceutical, Inc., USWM, LLC, Valeant Pharmaceuticals, Greenyard Pharmaceutical Ltd. Cipla Health Limited. Perrigo, Haleon Group of Companies, Ventus Medical, Glenmark and other prominent players.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global substance abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global substance abuse treatment market.

Market Segmentation

• Global Substance Abuse Treatment Market, By Type (Revenue, USD Bn, 2021 - 2033)
• Alcohol
• Opioids (e.g., heroin, prescription painkillers)
• Tobacco/nicotine
• Cocaine
• Marijuana
• Methamphetamines
• Other illicit drugs (Benzodiazepines, etc.)
• Global Substance Abuse Treatment Market, By Treatment Type (Revenue, USD Bn, 2021 - 2033)
• Opioid
  • Methadone
  • Buprenorphine
  • Extended-release naltrexone
  • Lofexidine
• Nicotine
  • Nicotine replacement therapies (available as a patch, inhaler, or gum)
  • Bupropion
  • Varenicline
• Alcohol
  • Naltrexone
  • Disulfiram
  • Acamprosate
• Tobacco
  • Clonidine
  • Nortriptyline
• Others (Topiramate, Modafinil, etc.)
• Global Substance Abuse Treatment Market, By Age Group (Revenue, USD Bn, 2021 - 2033)
• Adolescents
• Adults
• Geriatric
• Global Substance Abuse Treatment Market, By Treatment Setting (Revenue, USD Bn, 2021 - 2033)
• Outpatient Treatment
  • Outpatient Clinics
  • Private Practices
• Inpatient Treatment
  • Rehabilitation Centers
  • Hospitals
• Residential Treatment Facilities
• Detoxification Centers
• Global Substance Abuse Treatment Market, By Region (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Top Companies
• Indivior PLC
• Pfizer, Inc.
• Johnson & Johnson Inc.
• Mallinckrodt Pharmaceuticals
• Teva Pharmaceuticals, Inc.
• Par Pharmaceutical, Inc.
• USWM, LLC
• Valeant Pharmaceuticals
• Greenyard Pharmaceutical Ltd.
• Cipla Health Limited
• Perrigo
• Haleon Group of Companies
• Ventus Medical
• Glenmark
• Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Treatment Type
  • Market Snippet, By Age Group
  • Market Snippet, By Treatment Setting
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers:
    • Increasing consumption of drugs and alcohol
    • Growing support from government and NGOs
  • Restraints
    • Social stigma associated with substance dependence
    • Lack of adequate rehabilitation facilities
  • Opportunities
    • Untapped markets in developing countries
    • Company Market Share Analysis
• Key Highlights
• Market Trends
• PEST Analysis
• PORTER's Analysis
• Recent Product Approvals/Launches
• Mergers, Acquisitions, and Collaborations

4. Global Substance Abuse Treatment Market, By Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Alcohol
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Opioids (e.g., heroin, prescription painkillers)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Tobacco/nicotine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Cocaine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Marijuana
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Methamphetamines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Other illicit drugs (Benzodiazepines, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

5. Global Substance Abuse Treatment Market, By Treatment Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Opioid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
    • Methadone
    • Buprenorphine
    • Extended-release naltrexone
    • Lofexidine
• Nicotine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
    • Nicotine replacement therapies (available as a patch, inhaler, or gum)
    • Bupropion
    • Varenicline
• Alcohol
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
    • Naltrexone
    • Disulfiram
    • Acamprosate
• Tobacco
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
    • Clonidine
    • Nortriptyline
• Others (Topiramate, Modafinil, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

6. Global Substance Abuse Treatment Market, By Age Group, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Adolescents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

7. Global Substance Abuse Treatment Market, By Treatment Setting, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Outpatient Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
    • Outpatient Clinics
    • Private Practices
• Inpatient Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
    • Rehabilitation Centers
    • Hospitals
• Residential Treatment Facilities
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Detoxification Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

8. Global Substance Abuse Treatment Market, By Region, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2033
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profile
  • Indivior PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pfizer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Johnson & Johnson Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Mallinckrodt Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teva Pharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Par Pharmaceutical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • USWM, LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Valeant Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Greenyard Pharmaceutical Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Cipla Health Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Perrigo
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Haleon Group of Companies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ventus Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Glenmark
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Other Prominent Players
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
• Analyst Views

10. Section

• References
• Research Methodology
• About us